Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$34.7 million.

  • Standard Biotools' Profit After Tax fell 2876.61% to -$34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.3 million, marking a year-over-year decrease of 293.93%. This contributed to the annual value of -$138.9 million for FY2024, which is 8603.33% down from last year.
  • Standard Biotools' Profit After Tax amounted to -$34.7 million in Q3 2025, which was down 2876.61% from -$33.5 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Profit After Tax registered a high of -$9.4 million during Q4 2021, and its lowest value of -$76.3 million during Q1 2022.
  • For the 5-year period, Standard Biotools' Profit After Tax averaged around -$29.3 million, with its median value being -$26.0 million (2025).
  • Per our database at Business Quant, Standard Biotools' Profit After Tax crashed by 30533.45% in 2022 and then skyrocketed by 7792.18% in 2023.
  • Quarter analysis of 5 years shows Standard Biotools' Profit After Tax stood at -$9.4 million in 2021, then tumbled by 121.07% to -$20.8 million in 2022, then grew by 5.13% to -$19.8 million in 2023, then plummeted by 72.29% to -$34.1 million in 2024, then fell by 1.81% to -$34.7 million in 2025.
  • Its last three reported values are -$34.7 million in Q3 2025, -$33.5 million for Q2 2025, and -$26.0 million during Q1 2025.